TELA BIO, INC. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Net Debt Issuance
Cash Flow
Cash Flow by Activity
Operating Cash Flow↑+32.4% +$5M
$-10M
Free Cash Flow↑+65.5% +$173K
$-91K
Investing Cash Flow
$192K
Financing Cash Flow↓-39.8% -$17M
$26M
Capex↓-65.5% -$173K
$91K
Stock-Based Comp↓-25.4% -$277K
$812K
Debt Issued
—
Debt Repaid
$12M
D&A↓-24.0% -$41K
$130K
SBC Allocated Expense↓-25.4% -$277K
$812K